Benzoyl 2-methyl indoles as selective PPARγ modulators
摘要:
Routine screening for human PPAR ligands yielded compounds 1 and 2, both of which were sub-micromolar hPPARgamma agonists. Synthetic modifications of these leads led to a series of potent substituted 3-benzyl-2-methyl indoles, a subset of which were noted to be selective PPARgamma modulators (SPPARgammaMs). SPPARgammaM 24 displayed robust anti-diabetic activity with an improved therapeutic window in comparison to a PPARgamma full agonist in a rodent efficacy model. (C) 2004 Elsevier Ltd. All rights reserved.
Benzoyl 2-methyl indoles as selective PPARγ modulators
摘要:
Routine screening for human PPAR ligands yielded compounds 1 and 2, both of which were sub-micromolar hPPARgamma agonists. Synthetic modifications of these leads led to a series of potent substituted 3-benzyl-2-methyl indoles, a subset of which were noted to be selective PPARgamma modulators (SPPARgammaMs). SPPARgammaM 24 displayed robust anti-diabetic activity with an improved therapeutic window in comparison to a PPARgamma full agonist in a rodent efficacy model. (C) 2004 Elsevier Ltd. All rights reserved.
Compounds of formula (I)
and pharmaceutically acceptable salts thereof are agonists at the beta-2 adrenoceptor. They are useful as feed additives for livestock animals.
化学式为(I)的化合物及其药学上可接受的盐是β-2肾上腺素受体激动剂。它们可用作家畜饲料添加剂。
WO2008/44127
申请人:——
公开号:——
公开(公告)日:——
Orally effective inotropic compounds
申请人:IVAX LABORATORIES INCORPORATED
公开号:EP0146920B1
公开(公告)日:1988-02-17
HETEROCYCLIC COMPOUNDS USEFUL AS ANABOLIC AGENTS FOR LIVESTOCK ANIMALS
申请人:Pfizer Limited
公开号:EP2079747A1
公开(公告)日:2009-07-22
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
申请人:Merck Patent GmbH
公开号:US20170081317A1
公开(公告)日:2017-03-23
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.